Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-02-20 @ 6:34 PM
Study NCT ID:
NCT07095868
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2025-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors
Sponsor:
Everest Medicines (Beijing) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2029-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-11
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-24
First Submit QC Date:
None
Study First Post Date:
2025-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED